Skip to main content

Natera Inc

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

NTRA$311.98-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits and Financial Statement Schedules

ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(1)Financial Statements (included in Part II of this report):
●Report of Independent Registered Public Accounting Firm
●Balance Sheets
●Statement of Operations
●Statement of Stockholders’ Equity
●Statement of Cash Flows
●Notes to Financial Statements
(2)Financial Statement Schedules:

All financial statement schedules are omitted because the information is inapplicable or presented in the notes to the financial statements.

(b)The following exhibits are filed with or incorporated by reference as part of this Annual Report on Form 10-K:

INDEX TO EXHIBITS

​ · ​ · Incorporated by Reference
Exhibit No.DescriptionFormFile No.ExhibitFiling DateFiledHerewith
3.1Amended and Restated Certificate of Incorporation of Registrant.8-K001-374783.107/09/2015​
3.2Amended and Restated Bylaws of Registrant, effective as of November 3, 202110-Q001-374783.111/05/2021​
4.1Form of Common Stock CertificateS-1/A333-2046224.106/22/2015​
4.2Amended and Restated Investors' Rights Agreement, dated November 20, 2014.S-1333-2046224.206/01/2015​
4.3Description of Common Stock10-K001-374784.302/26/2021​
4.4Indenture (including form of Note) with respect to the Company’s 2.25% Convertible Senior Notes due 2027, dated as of April 16, 2020, between the Registrant and Wilmington Trust, National Association, as trustee8-K001-374784.104/16/2020​
10.1.1UBS Credit Line Agreement, dated September 23, 2015, as amended.10-Q001-3747810.211/13/2015​
10.1.2Amendment to UBS Credit Line Agreement, dated July 5, 2017.10-Q001-3747810.108/09/2017​
10.2.1*Supply Agreement, dated September 18, 2014, by and between Registrant and Illumina, Inc., as amended (conformed copy).S-1/A333-20462210.1306/30/2015​
10.2.2*Second Amendment to Supply Agreement, dated September 21, 2015, by and between Registrant and Illumina, Inc.10-Q001-3747810.108/11/2016​
10.2.3*Third Amendment to Supply Agreement, dated June 8, 2016, by and between Registrant and Illumina, Inc.10-Q001-3747810.208/11/2016​
10.2.4*Fourth Amendment to Supply Agreement, dated January 3, 2019, by and between Registrant and Illumina, Inc.10-K001-3747810.803/15/2019​
10.2.5**Fifth Amendment to Supply Agreement, dated December 18, 2019, by and between Registrant and Illumina, Inc.10-K001-3747810.5.503/02/2020​
10.2.6**Sixth Amendment to Supply Agreement, dated May 8, 2020, by and between Registrant and Illumina, Inc.10-Q001-3747810.108/07/2020​
10.2.7**Seventh Amendment to Supply Agreement, dated October 7, 2021, by and between the Registrant and Illumina, Inc.10-Q001-3747810.111/05/2021​
10.2.8**Eighth Amendment to Supply Agreement, dated December 31, 2023, by and between the Registrant and Illumina, Inc.​​​​X
​ · ​ · Incorporated by Reference
Exhibit No.DescriptionFormFile No.ExhibitFiling DateFiledHerewith
10.3.1*Application Service Provider Agreement, dated September 19, 2014, by and between Registrant and DNAnexus, Inc., as amended10-K001-3747810.1103/16/2017​
10.3.2*Third Amendment to Application Service Provider Agreement, dated January 1, 2018, by and between Registrant and DNAnexus, Inc.10-Q001-3747810.111/09/2018​
10.3.3*Fourth Amendment to Application Service Provider Agreement, dated July 1, 2018, by and between Registrant and DNAnexus, Inc.10-Q001-3747810.211/09/2018​
10.3.4*Fifth Amendment to Application Service Provider Agreement, dated October 18, 2019, by and between Registrant and DNAnexus, Inc.10-Q001-3747810.211/08/2019​
10.4*License, Development and Distribution Agreement, dated as of March 9, 2018, by and between Registrant and QIAGEN LLC10-Q/A001-3747810.102/06/2019​
10.5.1Lease, dated October 26, 2015, by and between Registrant and BMR-201 Industrial Road LP.10-K001-3747810.2303/24/2016​
10.5.2First Amendment to Lease, dated October 6, 2016, by and between Registrant and BMR-201 Industrial Road LP.10-Q001-3747810.111/14/2016​
10.6.1Lease Agreement dated September 24, 2015, by and between NSTX, Inc. and Karlin McCallen Pass, LLC.10-Q001-3747810.111/09/2022​
10.6.2First Amendment to Lease Agreement dated January 26, 2016, by and between NSTX, Inc. and Karlin McCallen Pass, LLC.10-Q001-3747810.211/09/2022​
10.6.3Second Amendment to Lease Agreement dated March 10, 2021, by and between NSTX, Inc. and KCP Parmer 3.2 Fee Owner, LLC.10-Q001-3747810.311/09/2022​
10.6.4Third Amendment to Lease Agreement dated December 29, 2021, by and between NSTX, Inc. and 13011 McCallen Pass, LLC.10-Q001-3747810.411/09/2022.
10.7***2007 Stock Plan and form of agreements thereunder.S-1333-20462210.106/01/2015​
10.8***2015 Equity Incentive Plan and forms of agreements thereunder.10-K001-3747810.203/24/2016​
10.9***2015 Employee Stock Purchase Plan.S-1/A333-20462210.306/25/2015​
10.10Form of Indemnification Agreement, by and between Registrant and each of its directors and executive officers.10-K001-3747810.403/16/2017​
10.11.1***Amended Compensation Program for Non-Employee Directors.10-Q001-3747810.205/10/2019​
​ · ​ · Incorporated by Reference
Exhibit No.DescriptionFormFile No.ExhibitFiling DateFiledHerewith
10.11.2***Amended and Restated Compensation Program for Non-Employee Directors.8-K001-3747810.103/14/2022​
10.11.3***Amended Compensation Program for Non-Employee Directors.10-Q001-3747810.105/10/2023​
10.11.4***Amended Compensation Program for Non-Employee Directors.10-Q001-3747810.208/04/2023​
10.12***Natera, Inc. Management Cash Incentive Plan.10-Q001-3747810.311/13/2015​
10.13.1***Amended Employment Agreement, by and between Registrant and Matthew Rabinowitz, dated June 7, 2007.S-1/A333-20462210.1506/25/2015​
10.13.2***Amendment to Employment Agreement, by and between Registrant and Matthew Rabinowitz, dated May 9, 2021.8-K001-3747810.205/10/2021​
10.13.3***Second Amendment to Employment Agreement, by and between Registrant and Matthew Rabinowitz, dated April 19, 2023.10-Q001-3747810.108/04/2023​
10.14***Amended Employment Agreement, by and between Registrant and Jonathan Sheena, dated June 7, 2007.S-1/A333-20462210.1606/25/2015​
10.15.1***Amended and Restated Employment Agreement, by and between Registrant and Steve Chapman, dated January 2, 2019.10-Q001-3747810.105/10/2019​
10.15.2***Amendment No. 1 to Amended and Restated Employment Agreement, by and between Registrant and Steve Chapman, dated May 4, 202210-Q001-3747810.105/06/2022​
10.16***Amended Employment Agreement, by and between Registrant and Daniel Rabinowitz, dated June 7, 2007.10-Q001-3747810.108/05/2022​
21.1List of Subsidiaries of the Registrant.10-K001-3747821.103/16/2017
23.1Consent of Independent Registered Public Accounting Firm.​X
31.1Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​X
31.2Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.​X
​​Incorporated by Reference
Exhibit No.DescriptionFormFile No.ExhibitFiling DateFiledHerewith
32.1†Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​X
32.2†Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.​X
97.1***Natera, Inc. Policy for the Recovery of Erroneously Awarded Compensation.​​​​X
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.​X
101.SCHXBRL Taxonomy Extension Schema Document.​X
101.CALXBRL Taxonomy Extension Calculation Linkbase Document.​X
101.DEFXBRL Taxonomy Extension Definition Linkbase Document.​X
101.LABXBRL Taxonomy Extension Label Linkbase Document.​X
101.PREXBRL Taxonomy Extension Presentation Linkbase Document.​X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)​​​​X
*Portions of this exhibit (indicated by asterisks) have been omitted pursuant to an order granting confidential treatment. Omitted portions have been submitted separately to the Securities and Exchange Commission (SEC).

** Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment.

***Indicates a management contract or compensatory plan.
†The certifications attached as Exhibits 32.1 and 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the SEC and are not to be incorporated by reference into any filing of Natera, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language contained in any filing.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.